Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology
2020/05/28 by James Neuberger, Jai V. Patel, Jai Patel +13 · 28 citations
Medicine · #Liver Disease Diagnosis and Treatment #Liver Disease and Transplantation #Pancreatitis Pathology and Treatment
paper · pdf · doi:10.1136/gutjnl-2020-321299
Abstract
Liver biopsy is required when clinically important information about the diagnosis, prognosis or management of a patient cannot be obtained by safer means, or for research purposes. There are several approaches to liver biopsy but predominantly percutaneous or transvenous approaches are used. A wide choice of needles is available and the approach and type of needle used will depend on the clinical state of the patient and local expertise but, for non-lesional biopsies, a 16-gauge needle is recommended. Many patients with liver disease will have abnormal laboratory coagulation tests or receive anticoagulation or antiplatelet medication. A greater understanding of the changes in haemostasis in liver disease allows for a more rational, evidence-based approach to peri-biopsy management. Overall, liver biopsy is safe but there is a small morbidity and a very small mortality so patients must be fully counselled. The specimen must be of sufficient size for histopathological interpretation. Communication with the histopathologist, with access to relevant clinical information and the results of other investigations, is essential for the generation of a clinically useful report.
Citations
Cited by
- Noninvasive Detection of Occult yet Significant Liver Pathology in Alanine Aminotransferase–Normal Chronic Hepatitis B: A Multicenter Study
- Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
- Charting new territory: outpatient stewardship in immunocompromised patients (first of a two-part series)
- Hepatic Steatosis Predicts Higher Incidence of Recurrence in Colorectal Cancer Liver Metastasis Patients. [europepmc]
- Thrombocytopenia and Hemostatic Changes in Acute and Chronic Liver Disease: Pathophysiology, Clinical and Laboratory Features, and Management. [europepmc]
- The Need for Alternatives to Liver Biopsies: Non-Invasive Analytics and Diagnostics. [europepmc]
- Diagnostic Yield of Endoscopic Ultrasound-Guided Liver Biopsy in Comparison to Percutaneous Liver Biopsy: A Two-Center Experience. [europepmc]
- Patient understanding and experience of non-invasive imaging diagnostic techniques and the liver patient pathway. [europepmc]
- Non-alcoholic fatty liver disease: A patient guideline. [europepmc]
- Breath-Taking Perspectives and Preliminary Data toward Early Detection of Chronic Liver Diseases. [europepmc]
- Nephrologists' Attitudes Toward Native Kidney Biopsy: A Qualitative Study. [europepmc]
- Diagnostic efficacy of FibroScan for liver inflammation in patients with chronic hepatitis B: a single-center study with 1185 liver biopsies as controls. [europepmc]
- An Expert, Multidisciplinary Perspective on Best Practices in Biomarker Testing in Intrahepatic Cholangiocarcinoma. [europepmc]
- Hepatic Steatosis Index and the Risk of Type 2 Diabetes Mellitus in China: Insights from a General Population-Based Cohort Study. [europepmc]
- Effect of cofactors on NAFLD/NASH and MAFLD. A paradigm illustrating the pathomechanics of organ dysfunction. [europepmc]
- Predicting bleeding after liver biopsy using comprehensive clinical and laboratory investigations: A prospective analysis of 302 procedures. [europepmc]
- Advancements in MAFLD Modeling with Human Cell and Organoid Models. [europepmc]
- The spectrum of magnetic resonance imaging proton density fat fraction (MRI-PDFF), magnetic resonance spectroscopy (MRS), and two different histopathologic methods (artificial intelligence vs. pathologist) in quantifying hepatic steatosis. [europepmc]
- The Accuracy of Ultrasound Controlled Attenuation Parameter in Diagnosing Hepatic Fat Content. [europepmc]
- Spatial Omics Imaging of Fresh-Frozen Tissue and Routine FFPE Histopathology of a Single Cancer Needle Core Biopsy: A Freezing Device and Multimodal Workflow. [europepmc]
- Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Elastography to Evaluate the Early Effects of Bariatric Surgery on Nonalcoholic Fatty Liver Disease. [europepmc]
- Tips for Preparing and Practicing Thermal Ablation Therapy of Hepatocellular Carcinoma. [europepmc]
- Reproducibility and Repeatability of Intravoxel Incoherent Motion MRI Acquisition Methods in Liver. [europepmc]
- Expert opinion on bleeding risk from invasive procedures in cirrhosis. [europepmc]
- NAFLD in the 21st Century: Current Knowledge Regarding Its Pathogenesis, Diagnosis and Therapeutics. [europepmc]
- Erythropoietic protoporphyrias: Pathogenesis, diagnosis and management. [europepmc]
- Modernizing metabolic dysfunction-associated steatotic liver disease diagnostics: the progressive shift from liver biopsy to noninvasive techniques. [europepmc]
- Cardiovascular, Kidney, Liver, and Metabolic Interactions in Heart Failure: Breaking Down Silos. [europepmc]
Related